Angela Smith, MD, MS, won for her outstanding leadership and contributions in bladder cancer outcomes research.
Angela Smith, MD, MS, won the 2022 Gold Cystoscope Award from the American Urological Association for outstanding leadership and contributions in bladder cancer outcomes research. Only one recipient is chosen for the award internationally each year, and recipients are chosen for their outstanding contributions to the profession.
Smith is Vice Chair for Academic Affairs, Director of Urologic Oncology, and Associate Professor of Urology in the UNC School of Medicine. She received her medical degree and Masters of Science in Clinical Research from UNC-Chapel Hill, where she also completed her urology residency. She is the Director of Urologic Oncology at the UNC Lineberger Comprehensive Cancer Center where she treats GU malignancies, including bladder, prostate and kidney cancer.
Smith has a background in health services research and biostatistics with particular interests in patient-centered outcomes research, risk stratification, and quality of care for invasive bladder cancer. She is the co-PI for a PCORI large pragmatic trial in BCG refractory bladder cancer, PI for a PCORI Engagement Award with the Bladder Cancer Advocacy Network to engage patients in the research process, and has been funded by an AHRQ K08 grant that integrates patient-reported outcomes into post-cystectomy care through mobile health technology. She has previously served on the PCORI Advisory Panel for the Assessment of Prevention, Diagnosis and Treatment Options, representing clinicians. Dr. Smith also serves as the Assistant Secretary of the American Urological Association and is on the AUA Quality Improvement and Patient Safety Committee, Scientific Advisory Board for the Bladder Cancer Advocacy Network, Journal of Urology Editorial Board, and chair of the Urology Care Foundation Bladder Health Committee.